We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mipomersen Phase 3 Study in Patients with Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint

News   Feb 11, 2010

 
Mipomersen Phase 3 Study in Patients with Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint
 
 
 

RELATED ARTICLES

Schizophrenia: Hippocampus Drastically Shrinks in Adolescents With Psychotic Symptoms

News

Schizophrenia may be related to genetic abnormalities of chromosome 22, known as 22q11 deletion syndrome. However, not everyone who has the syndrome necessarily develops psychotic symptoms. So, what triggers the illness? An 18-year-long study provides some answers.

READ MORE

Shoulder Pain Relief for Wheelchair Users With Spinal Cord Injury

News

Researchers report initial results for a minimally invasive intervention for relief of chronic refractory shoulder pain in upper-limb dependent individuals with spinal cord injury.

READ MORE

Mutation Discovery Could Help Treat Children With Developmental Disorders

News

Analysis of 31,000 parent-child trios yielded more than 45,000 de novo mutations (DNMs). Researchers developed an improved method to test for the enrichment (over-representation) of damaging DNMs in individual genes and found 307 significantly enriched genes, 49 of which are novel.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE